Multi-Matrix
Multi-Matrix, licence 80006829: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80006829
- Status
- Inactive licence
- Licence date
- 25 July 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 179.56 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 400 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 76 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Iode: up to 152 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSAEuropean Food Safety Authority. for adults (8 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 76 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacinamide Source : Niacinamide | 15.0 mg | Not calculated |
| Manganèse Source : Citrate de manganèse (II) | 2.25 mg | 9,000 µg |
| Vitamine E Source : d-alpha-tocophérol | 67.0 UI | Not calculated |
| Vitamine E Source : d-alpha-tocophérol | 44.89 mg | 179,560 µg |
| Vitamine C Source : Acide ascorbique | 100.0 mg | 400,000 µg |
| Choline Source : Dihydrogénocitrate de choline | 10.0 mg | Not calculated |
| Folate Source : Acide folique | 130.0 mcg | Not calculated |
| bêta-carotène Source : Bêta carotène | 249.0 mcg EAR | Not calculated |
| Sélénium Source : Citrate de sélénium | 50.0 mcg | 200 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 19.0 mg | 76,000 µg |
| Biotine Source : Biotine | 125.0 mcg | 500 µg |
| Iode Source : Iodure de potassium | 38.0 mcg | 152 µg |
Non-medicinal ingredients
Hypromellose, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
A multi-vitamin/mineral supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if pregnant or breastfeeding, have a liver disorder or if you have a history of non-melanoma skin cancer.
Source
Official Health Canada record, licence 80006829
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.